Review of 177Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer

Prostate-specific membrane antigen (PSMA) is a cell membrane glycoprotein that is selectively expressed in prostate cells, with expression levels increasing dramatically in prostatic adenocarcinoma. PSMA-based radioligand therapy (RLT) has emerged as a viable therapeutic modality for the treatment o...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cureus
Päätekijät: Sun, Michael, Niaz, Muhammad O, Nelson, Adlai, Skafida, Myrto, Niaz, Muhammad J
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Cureus 2020
Aiheet:
Internal Medicine
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7392183/
https://ncbi.nlm.nih.gov/pubmed/32760622
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.8921
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia